ocr: Company/Institution Compound Status EntreMed Thalidomide Phase II RepliGen Platelet factor 4 Phase II Takeda AGM-1470 Phase I/II Hoffman-La Roche Interleukin-12 Phase I British Biotechnology BB2516 (Marimastat) Phase I Daiichi Pharmaceuticals Tecogalan Phase I Hadasic Polysulfated polysaccharide from seaweed cell walls Phase I NIH (USA) CAI Phase I Warner-Lambert CI-994 Phase I Carbomed CM101 Phase I Antsoma/lnsutute for Molecular Medicine Anti-ED-B (fibronectin domain) MAb Preclinical Argonex OLX-514 Preclinical Cell Therapeutics CT-2584 Preclinical Collagenex Metastat Preclinical EntreMed Br ...
